Company intelligence / Profile preview

Petrus Holding

Oslo, Norway

Ownership: Private
Development stage: Other

Overview

Petrus Holding AS is a Norwegian private investment and holding company primarily known in the life sciences sector for its significant ownership stake in Olink Holding AB, a leading proteomics company. Led by Jon Hindar, a prominent executive with extensive experience in the biotechnology and industrial sectors, the company acts as a strategic investment vehicle. Petrus Holding played a key role as a supporting shareholder during the acquisition of Olink by Thermo Fisher Scientific, which was completed in 2024. While not a drug developer itself, the company's portfolio and leadership are deeply integrated into the European life sciences and biotechnology investment landscape.

Industry: Investors

Partnerships

Olink Holding ABThermo Fisher Scientific

Beyond the preview

Go deeper on Petrus Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Petrus Holding.

Explore the full profile